Protocol Ledger

NCT07060443 · Phase II · RECRUITING

Fluorescence Lymph Node Mapping for Colon Cancer Surgery

Interventional Phase II clinical trial protocol NCT07060443 sponsored by Pusan National University Yangsan Hospital in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2025-07-23 Enrollment: 186 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT07060443
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)186 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT07060443
Protocol FieldVerified Registry Value
NCT IdentifierNCT07060443
Consolidated Lead SponsorPusan National University Yangsan Hospital
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment186 participants (ESTIMATED)
Registered Start Date2025-07-23
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT07060443
Hospital Research SiteLocationSite Profile
Kyungpook National University Chilgok HospitalDaegu, South KoreaOpen Hospital Dossier ->
Chungnam National University HospitalDaejeon, South KoreaOpen Hospital Dossier ->
Chonnam National University Hwasun HospitalHwasun, South KoreaOpen Hospital Dossier ->
Gachon University Gil Medical CenterIncheon, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI